P4 and P1′ optimization of bicycloproline P2 bearing tetrapeptidyl α-ketoamides as HCV protease inhibitors
- 4 October 2004
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 14 (19) , 5007-5011
- https://doi.org/10.1016/j.bmcl.2004.07.007
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Inhibitors of hepatitis C virus NS3·4A protease. Part 3: P2 proline variantsBioorganic & Medicinal Chemistry Letters, 2004
- Inhibitors of hepatitis C virus NS3·4A protease 2. Warhead SAR and optimizationBioorganic & Medicinal Chemistry Letters, 2004
- Discovery of a novel bicycloproline P2 bearing peptidyl α-ketoamide LY514962 as HCV protease inhibitorBioorganic & Medicinal Chemistry Letters, 2004
- Novel P4 truncated tripeptidyl α-ketoamides as HCV protease inhibitorsBioorganic & Medicinal Chemistry Letters, 2004
- Hepatitis C Virus Therapies: Current Treatments, Targets and Future PerspectivesAntiviral Chemistry and Chemotherapy, 2003
- 5 Inhibitors of Hepatitis C Virus NS3•4A Protease: An Overdue Line of TherapyProgress in Medicinal Chemistry, 2002
- Emerging therapies for hepatitis C virus infectionEmerging Drugs, 2001
- Novel Approaches to the Treatment of Hepatitis C Virus InfectionAntiviral Chemistry and Chemotherapy, 2000
- Hepatitis C virus NS3/4A proteaseAntiviral Research, 1998
- Molecular Targets in Inhibition of Hepatitis C Virus ReplicationAntiviral Chemistry and Chemotherapy, 1997